Busulfan-Cyclophosphamide versus Cyclophosphamide-Busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

被引：0
|
作者：
Seydoux, C. [1 ]
Medinger, M. [1 ]
Gerull, S. [1 ]
Halter, J. [1 ]
Heim, D. [1 ]
Chalandon, Y. [2 ,3 ]
Levrat, Masouridi S. [2 ,3 ]
Schanz, U. [4 ]
Nair, G. [4 ]
Simon, P. [5 ]
Passweg, J. R. [1 ]
Cantoni, N. [6 ]
机构：
[1] Univ Hosp Basel, Div Hematol, Basel, Switzerland
[2] Univ Hosp Geneva, Bone Marrow Transplant Unit, Div Hematol, Geneva, Switzerland
[3] Univ Geneva, Fac Med, Geneva, Switzerland
[4] Univ Zurich, Stem Immune Cell Transplant Unit, Dept Med Oncol & Hematol, Zurich, Switzerland
[5] Basel Univ, Dept Clin Res, Clin Trials Unit, Basel, Switzerland
[6] Kantonsspital Aarau, Div Oncol Hematol & Transfus Med, Aarau, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [21] REGIMEN-RELATED TOXICITY OF A BUSULFAN-CYCLOPHOSPHAMIDE CONDITIONING REGIMEN IN 70 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEVILL, TJ
    BARNETT, MJ
    KLINGEMANN, HG
    REECE, DE
    SHEPHERD, JD
    PHILLIPS, GL
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1224 - 1232
  • [22] TREATMENT OF MYELODYSPLASTIC SYNDROME WITH BUSULFAN-CYCLOPHOSPHAMIDE CONDITIONING FOLLOWED BY ALLOGENEIC BMT
    NEVILL, TJ
    SHEPHERD, JD
    REECE, DE
    BARNETT, MJ
    NANTEL, SH
    KLINGEMANN, HG
    PHILLIPS, GL
    BONE MARROW TRANSPLANTATION, 1992, 10 (05) : 445 - 450
  • [23] Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies
    Mori, Takehiko
    Ohashi, Kazuteru
    Kanamori, Heiwa
    Sakura, Toru
    Yano, Shingo
    Kanda, Yoshinobu
    Kako, Shinichi
    Tachibana, Takayoshi
    Yokota, Akira
    Onizuka, Makoto
    Nakaseko, Chiaki
    Okamoto, Shinichiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S204 - S204
  • [24] LONG TERM FOLLOW-UP OF THE MULTICENTRE, RANDOMIZED PHASE 3 TRIAL COMPARING BUSULFAN-FLUDARABINE VERSUS BUSULFAN-CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTATION
    Cavallaro, Gianluca
    Grassi, Anna
    Pavoni, Chiara
    Mico, Maria Caterina
    Busca, Alessandro
    Cavattoni, Irene Maria
    Santarone, Stella
    Borghero, Carlo
    Olivieri, Attilio
    Milone, Giuseppe
    Chiusolo, Patrizia
    Musto, Pellegrino
    Saccardi, Riccardo
    Patriarca, Francesca
    Pane, Fabrizio
    Saporiti, Giorgia
    Rivela, Paolo
    Terruzzi, Elisabetta
    Cerretti, Raffaella
    Marotta, Giuseppe
    Carella, Angelo Michele
    Nagler, Arnon
    Russo, Domenico
    Corradini, Paolo
    Bernasconi, Paolo
    Iori, Anna Paola
    Castagna, Luca
    Mordini, Nicola
    Oldani, Elena
    Di Grazia, Carmen
    Bacigalupo, Andrea
    Rambaldi, Alessandro
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 52 - 53
  • [25] Comparison of BuCy (Busulfan plus Cyclophosphamide) Versus FluBu4 (Fludarabine plus Busulfan) As a Conditioning Regimen for Allogeneic Stem Cell Transplantation
    Park, Silvia
    Hong, Jung Yong
    Choi, Moon Ki
    Kim, Young Saing
    Lee, Ji Yun
    Lim, Sung Hee
    Jung, Chul Won
    Jang, Jun Ho
    Kim, Kihyun
    BLOOD, 2012, 120 (21)
  • [26] Application of the Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Xu, Yun
    Yao, Ying
    Yao, Weiqin
    Jin, Song
    Yan, Lingzhi
    Shang, Jingjing
    Fu, Chengcheng
    Wu, Depei
    BLOOD, 2017, 130
  • [27] APPLICATION OF CONDITIONING REGIMEN WITH BUSULFAN AND CYCLOPHOSPHAMIDE IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Xu, Y.
    Fu, C.
    Yao, Y.
    Yao, W.
    Jin, S.
    Yan, L.
    Shang, J.
    Zhu, X.
    Sun, A.
    Wu, D.
    HAEMATOLOGICA, 2017, 102 : 787 - 787
  • [28] Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning
    McCune, Jeannine S.
    Wang, Tao
    Bo-Subait, Khalid
    Aljurf, Mahmoud
    Beitinjaneh, Amer
    Bubalo, Joseph
    Cahn, Jean-Yves
    Cerny, Jan
    Chhabra, Saurabh
    Cumpston, Aaron
    Dupuis, L. Lee
    Lazarus, Hillard M.
    Marks, David I.
    Maziarz, Richard T.
    Norkin, Maxim
    Prestidge, Tim
    Mineishi, Shin
    Krem, Maxwell M.
    Pasquini, Marcelo
    Martin, Paul J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1424 - 1431
  • [29] Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine
    Lee, Je-Hwan
    Joo, Young-Don
    Kim, Hawk
    Ryoo, Hun Mo
    Kim, Min Kyoung
    Lee, Gyeong-Won
    Lee, Jung-Hee
    Lee, Won-Sik
    Park, Jae-Hoo
    Bae, Sung-Hwa
    Hyun, Myung Soo
    Kim, Dae-Young
    Kim, Sung-Doo
    Min, Young Joo
    Lee, Kyoo-Hyung
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 701 - 709
  • [30] Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen
    Arslan, O
    Akan, H
    Koc, H
    Beksac, M
    Ilhan, O
    Ozcan, M
    Yalcin, S
    Gurman, G
    Konuk, N
    Uysal, A
    BONE MARROW TRANSPLANTATION, 1996, 18 (01) : 261 - 261
12345